SUPREP Bowel Prep (sodium sulfate, potassium sulfate, magnesium sulfate)
**Product type:** Human Prescription Drug
**Active ingredient:** MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE
**Strength:** 1.2; 2.35; 13.13 g/133.1mL; g/133.1mL; g/133.1mL
**Dosage form:** Solution, Concentrate
**Route:** Oral
**Labeler:** Azurity Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA022372)
**Pharmacologic class:** Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
/api/v1/systems/ndc_fda/nodes/24338-177Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.